Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
CG Oncology, Inc. (CGON), most recent 12 months reported: revenue $6.23M, net loss $224.38M, free cash flow -$179.34M. Latest balance sheet on file: liquid cash $1.03B, total debt $3M, net cash $1.03B. From SEC filings. More on CG Oncology, Inc.: Revenue · Profitability · Debt Others in Biological Products, (No Diagnostic Substances): Caribou Biosciences, Inc. · TSCAN THERAPEUTICS, INC. · ZEO SCIENTIFIX, INC · FATE THERAPEUTICS INC · Taysha Gene Therapies, Inc. · DBV Technologies S.A. · Prime Medicine, Inc. · OCUGEN, INC.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.